Skip to content
Sunday 23 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 07 February 2024 6:00 am  |  Updated:  Tuesday 06 February 2024 9:21 pm

Bank of England’s bond sales a ‘leap into the dark’, warn MPs – with £130bn of taxpayers’ cash in play

By: Chris Dorrell

Add as a preferred source on Google
Investors are predicting more interest rate cuts this year than they previously had.
Investors are predicting more interest rate cuts this year than they previously had.

The Bank of England’s quantitative tightening (QT) programme is a “leap in the dark” which has not yet been adequately stress-tested, MPs have warned.

In a report published today, the influential Treasury Committee argued that QT – in which the Bank sells government debt back into the market – was a “major monetary operation” on which experts were still divided – with some warning of a coming cost to the taxpayer.

Harriett Baldwin, chair of the Committee, described the decision to undertake a period of quantitative tightening as “a leap in the dark”.

“I recognise that the Bank of England does not have a crystal ball,” she said. “But more can be done to develop forecasting and modelling tools which can help us understand the risks and benefits of QT.”

While the report noted that there had been limited impact on financial stability from QT, the Committee did draw attention to the costs.

With the Treasury likely to foot a bill of over £100bn for QT, the MPs said it was “highly anomalous that decisions have been and are being taken concerning huge sums of public money without any regard to the usual value-for-money requirements”.

The Committee suggested that the Bank and the Treasury explore how value-for-money could be included in future decisions around the pace and timing of QT.

Following the financial crisis, the Bank started hoovering up government bonds on the secondary market in an attempt to stimulate the economy.

By 2021, the Bank’s stock of gilt purchases stood at £875bn.

Read more

How patient can the Bank of England be?

Historic Royal Exchange building in London with modern skyscrapers behind, clear blue sky.

To buy the bonds, the Bank created new commercial bank deposits on which it had to pay interest.

When interest rates were low, the yield the Bank received from government bonds exceeded the interest it had to pay on new commercial bank deposits.

However, as interest rates have risen, the costs of the programme now comfortably exceed the return from gilt yields.

Annual losses in 2023 and 2024 will amount to around £40bn, the report noted. Subsequent losses will mean the Treasury faces a total bill of between £50bn and £130bn. The substantial difference reflects the uncertainty over the future path of interest rates.

“With more public money at stake than was ever envisaged when QE was launched, the Bank and Treasury should take our advice and explore whether the usual value for money considerations can be factored in when deciding the pace and level of QT they implement,” Baldwin said.

The Committee also questioned whether the indemnity payments should be included in the government’s fiscal rules, which require the government to get debt falling.

“The current losses thereby have worrying implications for public spending, taxation and borrowing, and for the operational independence of monetary policy,” it said.

A Bank of England spokesperson said: “We welcome the Committee’s report and will consider its findings carefully before responding. We continue to encourage active debate about our monetary policy decisions and their implementation.”

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics
  • News

Categories

  • Economics

Trending Articles

  • Can debt-ridden Morrisons become a Big Four supermarket again?

  • Ratcliffe’s Ineos saves Runcorn plant

  • Mike Ashley’s Frasers offers to pay personal shoppers in Harvey Nichols takeover

  • Amazon says it buys books in bulk to ‘improve products’

  • Burnham predicted to raise taxes for ‘fundamental’ cost of living support

More from Morning Wire

  • How patient can the Bank of England be?

    AD
    Historic Royal Exchange building in London with modern skyscrapers behind, clear blue sky.
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Rupert Lowe axes pensions triple lock and pledges tax cuts in economic plan

    Politics
    Rupert Lowe, former Southampton FC chairman, smiles while holding files on a city street, wearing a suit and pink tie
  • El Nino heatwaves to ‘fuel inflation next year’

    Economics
    Firefighter in helmet and uniform watching a blazing forest fire at night, red glow in the sky
  • World Cup leads UK spending boost as confidence rebounds

    Banking
    Excited crowd celebrating, a man in an England jersey cheers with arms raised and beer splashing from a cup.
  • Soaring energy bills set to fuel inflation spike

    Economics
    Smartphone displaying an energy bill notification with British coins and a banknote nearby.
  • War and tax: How the UK economy could get knocked off course

    Economics
    Andy Burnham speaking at a public event, emphasizing local governance and policy changes, wearing a suit and gesturing pas...
  • Stamp duty on shares is ‘biggest handbrake’ says UK bank chief

    Markets
    LSEG logo on a large screen inside a modern building with stock tickers and glass ceilings.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook